Feng, Alina S. https://orcid.org/0000-0003-0903-5149
Haemel, Anna https://orcid.org/0009-0000-0400-9158
Article History
Received: 4 July 2025
Revised: 15 November 2025
Accepted: 24 November 2025
First Online: 30 January 2026
Declarations
:
: Anna Haemel is an investigator for AstraZeneca, Priovant, and Insmed (research grants paid to institution) and a consultant for CSL Behring (honoraria paid to institution). Other author(s) report no disclosures.
: Per University of California, San Francisco IRB Guidelines, this study does not constitute human subject research and is exempt from IRB approval.